Case number 2018-1247
Amarin Pharma, Inc. v. ITC > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 23, 2021 | 0 | AMARIN PHARMA, INC. v. ITC [OPINION - PRECEDENTIAL] [precedential] (0) |
| Dec 9, 2019 | 123 | The petition for writ of certiorari, [19-152], filed on 07/30/2019, was Denied on 12/09/2019. [655187] [JAB] [Entered: 12/10/2019 08:00 AM] (0) |
| Aug 2, 2019 | 122 | Petition for writ of Certiorari filed on 07/30/2019, and placed on the docket 08/01/2019, in the Supreme Court of the United States. Supreme Court #: 19-152, Amarin Pharma, Inc., et al. v. International Trade Commission, et al. [625749] [JAB] [Entered: 08/02/2019 03:01 PM] (0) |
| Jun 24, 2019 | 121 | Mandate issued to the United States International Trade Commission. Service as of this date by the Clerk of Court. [616419] [JAB] [Entered: 06/24/2019 02:59 PM] (0) |
| May 15, 2019 | 120 | Bill of Costs for Intervenors Royal DSM NV, DSM Marine Lipids Peru S.A.C., DSM Nutritional Products LLC, DSM Nutritional Products Canada, Inc. and Pharmavite LLC. Service: 05/15/2019 by email, US mail. Objection to Bill of Costs due on 05/29/2019. [607641] [18-1247] [Mark Davies] [Entered: 05/15/2019 03:23 PM] (0) |
| May 9, 2019 | 119 | Bill of Costs for Appellee ITC. Service: 05/09/2019 by email, US mail. Objection to Bill of Costs due on 05/23/2019. [606174] [18-1247] [Houda Morad] [Entered: 05/09/2019 10:45 AM] (0) |
| May 1, 2019 | 117 | OPINION filed for the court by Prost, Chief Judge; Wallach, Circuit Judge and Hughes, Circuit Judge. Dissenting opinion filed by Circuit Judge Wallach. Precedential Opinion. The petition for mandamus is denied as moot. [604273] [18-1247, 18-114] [JAB] [Entered: 05/01/2019 10:09 AM] (0) |
| May 1, 2019 | 118 | JUDGMENT filed. AFFIRMED. Terminated on the merits after oral argument. COSTS: Costs taxed against Appellant(s). Mandate to issue in due course. For information regarding costs, petitions for rehearing, and petitions for writs of certiorari click here. [604275] [JAB] [Entered: 05/01/2019 10:10 AM] (0) |
| Jun 8, 2018 | 114 | Submitted after ORAL ARGUMENT by Mr. Joseph Forrest Busa for US, Mr. Ashley Charles Parrish for Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Ltd., Ms. Houda Morad for ITC and Mark S. Davies, Esq. for Royal DSM NV, DSM Marine Lipids Peru S.A.C., DSM Nutritional Products LLC, DSM Nutritional Products Canada, Inc. and Pharmavite LLC. Panel: Judge: Prost , Judge: Wallach , Judge: Hughes. [527906] [JCP] [Entered: 06/08/2018 10:30 AM] (0) |
| Jun 8, 2018 | 115 | MOTION of Intervenors DSM Marine Lipids Peru S.A.C., DSM Nutritional Products Canada, Inc., DSM Nutritional Products LLC, Royal DSM NV and Pharmavite LLC to withdraw counsel Alec Schierenbeck [Consent: unopposed]. Service: 06/08/2018 by email, US mail. [528007] [18-1247] [Mark Davies] [Entered: 06/08/2018 01:34 PM] (0) |
| Jun 8, 2018 | 116 | **TEXT ONLY** ORDER granting motion to withdraw attorney Alec Schierenbeck [115] filed by Intervenors Royal DSM NV, DSM Marine Lipids Peru S.A.C., DSM Nutritional Products LLC, DSM Nutritional Products Canada, Inc. and Pharmavite LLC. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [528077] [JAB] [Entered: 06/08/2018 03:18 PM] (0) |
| May 16, 2018 | 112 | Notice to counsel for Intervenors Nordic Naturals, Inc. and Nordic Pharma, Inc.: The record of this case indicates that the response to the Oral Argument Order has not been filed. The response was due on or before 05/15/2018. Counsel must promptly docket the Response to Oral Argument Order event and designate which attorney will present argument for the parties. Service as of this date by the Clerk of Court. [522031] [JAB] [Entered: 05/16/2018 08:42 AM] (0) |
| May 16, 2018 | 113 | Response to oral argument order from the Intervenors Nordic Naturals, Inc. and Nordic Pharma, Inc. waiving oral argument. [18-1247] [Andrew Pratt] [Entered: 05/16/2018 10:21 AM] (0) |
| May 14, 2018 | 111 | Response to oral argument order from the Intervenors DSM Marine Lipids Peru S.A.C., DSM Nutritional Products Canada, Inc., DSM Nutritional Products LLC, Pharmavite LLC and Royal DSM NV. Designating Mark S. Davies to argue.. Designating 5 minutes for argument. [18-1247] [Mark Davies] [Entered: 05/14/2018 09:04 AM] (0) |
| May 11, 2018 | 109 | Response to oral argument order from the Appellee ITC. Designating Houda Morad to argue.. Designating 10 minutes for argument. [18-1247] [Houda Morad] [Entered: 05/11/2018 04:49 PM] (0) |
| May 11, 2018 | 110 | Response to oral argument order from the Appellants Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Ltd.. Designating Ashley C. Parrish to argue.. Designating 15 minutes for argument. Reserving 5 minutes for rebuttal. [18-1247] [Ashley Parrish] [Entered: 05/11/2018 04:54 PM] (0) |
| May 8, 2018 | 107 | RESPONSE of Intervenors DSM Marine Lipids Peru S.A.C., DSM Nutritional Products Canada, Inc., DSM Nutritional Products LLC, Pharmavite LLC and Royal DSM NV to the supplemental authority [106] filed by Appellants Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Ltd.. Service: 05/08/2018 by email. [520099] [18-1247] [Mark Davies] [Entered: 05/08/2018 03:09 PM] (2) |
| May 8, 2018 | 108 | RESPONSE of Appellee ITC to the supplemental authority [106] filed by Appellants Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Ltd.. Service: 05/08/2018 by email. [520140] [18-1247] [Houda Morad] [Entered: 05/08/2018 04:15 PM] (4) |
| May 3, 2018 | 106 | Citation of Supplemental Authority pursuant to Fed. R. App. P. 28(j) for Appellants Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Ltd.. Service: 05/03/2018 by email. [519003] [18-1247] [Ashley Parrish] [Entered: 05/03/2018 05:40 PM] (32) |
| May 2, 2018 | 104 | ORDER filed granting motion for leave to participate at oral argument [103] filed by Amicus Curiae US. By: Merits Panel (Per Curiam). Service as of this date by the Clerk of Court. [518529] [JAB] [Entered: 05/02/2018 03:27 PM] (2) |
| May 2, 2018 | 105 | Response to oral argument order from the Amicus Curiae US. Designating Joseph F. Busa to argue.. Designating 5 minutes for argument. [18-1247] [Joseph Busa] [Entered: 05/02/2018 03:42 PM] (0) |
| Apr 27, 2018 | 103 | MOTION of Amicus Curiae US for leave to participate at oral argument [Consent: unopposed]. Service: 04/27/2018 by email. [517411] [18-1247] [Joseph Busa] [Entered: 04/27/2018 03:27 PM] (5) |
| Apr 20, 2018 | 102 | NOTICE OF CALENDARING. Panel: 1806M. Case scheduled Jun 08, 2018 10:00 a.m. at the United States Court of Appeals for the Federal Circuit (Howard T. Markey National Courts Building, 717 Madison Place, NW Washington, DC 20439), Courtroom 201. Response to oral argument order due: 05/15/2018. Arguing counsel is required to check-in with the Clerk's Office, 4th Floor, Room 401, between 8:30 a.m. and 9:30 a.m. on the day of argument. Please review the Oral Argument Order. [515707] [JAB] [Entered: 04/20/2018 02:18 PM] (0) |
| Apr 19, 2018 | 98 | Notice from Intervenors DSM Marine Lipids Peru S.A.C., DSM Nutritional Products Canada, Inc., DSM Nutritional Products LLC, Pharmavite LLC and Royal DSM NV regarding conflicts with oral argument (July 9-13, 2018). Service: 04/19/2018 by email. [515224] [18-1247] [Mark Davies] [Entered: 04/19/2018 11:47 AM] (2) |
| Apr 19, 2018 | 99 | Notice from Appellants Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Ltd. regarding conflicts with oral argument (No Conflicts). Service: 04/19/2018 by email. [515237] [18-1247] [Ashley Parrish] [Entered: 04/19/2018 12:00 PM] (2) |
| Apr 19, 2018 | 100 | Notice from Amicus Curiae US regarding conflicts with oral argument (Monday, June 4, 2018). Service: 04/19/2018 by email. [515391] [18-1247] [Joseph Busa] [Entered: 04/19/2018 03:48 PM] (1) |
| Apr 19, 2018 | 101 | Notice from Intervenors Nordic Naturals, Inc. and Nordic Pharma, Inc. regarding conflicts with oral argument ((No Conflicts)). Service: 04/19/2018 by email. [515413] [18-1247] [Andrew Pratt] [Entered: 04/19/2018 04:28 PM] (2) |
| Apr 18, 2018 | 95 | Notice from Appellee ITC regarding conflicts with oral argument (The ITC has a conflict with respect to the August 2018 Court week.). Service: 04/18/2018 by email. [514857] [18-1247] [Houda Morad] [Entered: 04/18/2018 12:57 PM] (3) |
| Apr 18, 2018 | 96 | 6 paper copies of the Reply Brief [89] received from Appellants Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Ltd. [514930] [JAB] [Entered: 04/18/2018 03:03 PM] (0) |
| Apr 18, 2018 | 97 | 6 paper copies of the appendix Brief [92] received from Appellants Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Ltd. [514932] [JAB] [Entered: 04/18/2018 03:04 PM] (0) |
| Apr 17, 2018 | 94 | Notice to counsel for Appellants Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Ltd.: The record of this case indicates that the paper copies of reply brief [89] (see Fed. Cir. R. 30(a)(5) and Fed. Cir. R. 31(b)) have not been filed. The paper copies of the brief should be received by the court on or before 04/19/2018. Service as of this date by the Clerk of Court. [514179] [JAB] [Entered: 04/17/2018 02:49 PM] (0) |
| Apr 12, 2018 | 93 | Pursuant to Practice Note 34, counsel should advise the clerk of court of scheduling conflicts for the next three court weeks, or thereafter. When filing the notice of conflicts, counsel should docket the Notice Regarding Conflicts with Argument Dates event, which is found in the Calendar event category. The notice of conflict with oral argument is due on or before 04/19/2018. [512815] [JB] [Entered: 04/12/2018 10:59 AM] (0) |
| Apr 9, 2018 | 91 | TENDERED from Appellants Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Ltd.. Title: JOINT APPENDIX. Service: 04/09/2018 by email. [511720] [18-1247] [Ashley Parrish] [Entered: 04/09/2018 02:30 PM] (264) |
| Apr 9, 2018 | 92 | APPENDIX FILED for Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Ltd. [91]. Number of Pages: 264. Service: 04/09/2018 by email. The paper copies of the brief should be received by the court on or before 04/19/2018. [512812] [JB] [Entered: 04/12/2018 10:56 AM] (264) |
| Apr 3, 2018 | 88 | Entry of appearance for Thomas King-Sun Fu as of counsel for Intervenors DSM Marine Lipids Peru S.A.C., DSM Nutritional Products Canada, Inc., DSM Nutritional Products LLC, Pharmavite LLC and Royal DSM NV. Service: 04/03/2018 by email. [510396] [18-1247] [Thomas Fu] [Entered: 04/03/2018 05:27 PM] (2) |
| Apr 2, 2018 | 84 | Certificate of Interest for the Amicus Curiae Council for Responsible Nutrition. Service: 04/02/2018 by email. [509863] [18-1247] [Deanna Okun] [Entered: 04/02/2018 02:29 PM] (3) |
| Apr 2, 2018 | 85 | Certificate of Interest for the Amicus Curiae Global Organization for EPA and DHA Omega-3S. Service: 04/02/2018 by email. [509872] [18-1247] [Deanna Okun] [Entered: 04/02/2018 02:31 PM] (3) |
| Apr 2, 2018 | 86 | Amended Certificate of Interest for the Appellants Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Ltd.. Service: 04/02/2018 by email. [509979] [18-1247] [Ashley Parrish] [Entered: 04/02/2018 05:23 PM] (4) |
| Apr 2, 2018 | 87 | TENDERED from Appellants Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Ltd.. Title: REPLY BRIEF. Service: 04/02/2018 by email. [509982] [18-1247] [Ashley Parrish] [Entered: 04/02/2018 05:30 PM] (48) |
| Apr 2, 2018 | 89 | REPLY BRIEF FILED for Appellants Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Ltd. [87]. Number of Pages: 37. Service: 04/02/2018 by email. The paper copies of the brief should be received by the court on or before 04/11/2018. Appendix is due 04/09/2018. [510555] [CMP] [Entered: 04/04/2018 12:50 PM] (48) |
| Apr 2, 2018 | 90 | 6 paper copies of the Corrected Amicus Brief [82] received from Amici Curiae Council for Responsible Nutrition and Global Organization for EPA and DHA Omega-3S. [510961] [SJL] [Entered: 04/05/2018 02:40 PM] (0) |
| Mar 30, 2018 | 83 | Clerk's Note to the File: Certificates of Interest for Amicus Parties Council for Responsible Nutrition and Global Organization for EPA and DHA Omega-3S are due 04/13/2018. [509683] [CMP] [Entered: 03/30/2018 04:55 PM] (0) |
| Mar 29, 2018 | 80 | 6 paper copies of the Intervenor Brief [74] received from Intervenors DSM Marine Lipids Peru S.A.C., DSM Nutritional Products Canada, Inc., DSM Nutritional Products LLC, Nordic Naturals, Inc., Nordic Pharma, Inc., Pharmavite LLC and Royal DSM NV. [509197] [SJL] [Entered: 03/29/2018 02:48 PM] (0) |
| Mar 29, 2018 | 81 | 6 paper copies of the Corrected Amicus Brief [79] received from Amicus Curiae US. [509311] [SJL] [Entered: 03/29/2018 04:18 PM] (0) |
| Mar 28, 2018 | 78 | TENDERED from COUNCIL FOR RESPONSIBLE NUTRITION AND GLOBAL ORGANIZATION FOR EPA AND DHA OMEGA-3S Title: CORRECTED AMICUS CURIAE BRIEF. Service: 03/28/2018 by email. [508756] [18-1247] [Deanna Okun] [Entered: 03/28/2018 03:03 PM] (42) |
| Mar 28, 2018 | 82 | CORRECTED AMICUS BRIEF FILED for Council for Responsible Nutrition and Global Organization for EPA and DHA Omega-3S [78]. Number of Pages: 29. Service: 03/28/2018 by email. The paper copies of the brief should be received by the court on or before 04/06/2018. [509681] [CMP] [Entered: 03/30/2018 04:54 PM] (42) |
| Mar 27, 2018 | 75 | NOTICE OF REJECTION: The brief of Council for Responsible Nutrition and Global Organization for EPA and DHA Omega-3s, Brief of Amicus Curiae [66], is not in compliance with the rules of this court and is therefore rejected for filing. Service as of this date by the Clerk of Court. [508351] [CMP] [Entered: 03/27/2018 03:29 PM] (2) |
| Mar 27, 2018 | 76 | NOTICE OF REJECTION: The brief of United States, Brief for Amicus Curiae [73], is not in compliance with the rules of this court and is therefore rejected for filing. Service as of this date by the Clerk of Court. [508381] [CMP] [Entered: 03/27/2018 04:00 PM] (2) |
| Mar 27, 2018 | 77 | TENDERED from United States of America Title: CORRECTED AMICUS CURIAE BRIEF. Service: 03/27/2018 by email. [508416] [18-1247] [Joseph Busa] [Entered: 03/27/2018 04:55 PM] (38) |
| Mar 27, 2018 | 79 | CORRECTED AMICUS BRIEF FILED for US [77]. Number of Pages: 29. Service: 03/27/2018 by email. The paper copies of the brief should be received by the court on or before 04/04/2018. [508826] [CMP] [Entered: 03/28/2018 04:34 PM] (38) |
| Mar 26, 2018 | 71 | 6 paper copies of the Opening Response Brief [62] received from Appellee ITC. [507841] [SJL] [Entered: 03/26/2018 11:39 AM] (0) |
| Mar 26, 2018 | 72 | Entry of appearance for Joseph F. Busa as principal counsel for United States of America. Service: 03/26/2018 by email. [507901] [18-1247] [Joseph Busa] [Entered: 03/26/2018 01:03 PM] (1) |
| Mar 26, 2018 | 73 | TENDERED from United States of America Title: AMICUS CURIAE BRIEF. Service: 03/26/2018 by email. [507903] [18-1247] This brief has been rejected. See Doc No. [76]. [Joseph Busa] [Entered: 03/26/2018 01:14 PM] (0) |
| Mar 22, 2018 | 64 | Certificate of Interest for the Intervenors Nordic Naturals, Inc. and Nordic Pharma, Inc.. Service: 03/22/2018 by email. [507305] [18-1247] [Andrew Pratt] [Entered: 03/22/2018 04:37 PM] (3) |
| Mar 22, 2018 | 65 | Docketing Statement for the Intervenors Nordic Naturals, Inc. and Nordic Pharma, Inc.. Service: 03/22/2018 by email. [507308] [18-1247] [Andrew Pratt] [Entered: 03/22/2018 04:39 PM] (3) |
| Mar 22, 2018 | 66 | TENDERED from Council for Responsible Nutrition and Global Organization for EPA and DHA Omega-3s Title: AMICUS CURIAE BRIEF. Service: 03/22/2018 by email. [507388] [18-1247] This brief has been rejected. See Doc No. [75]. [Deanna Okun] [Entered: 03/22/2018 07:37 PM] (0) |
| Mar 22, 2018 | 67 | Entry of appearance for Deanna Tanner Okun as principal counsel for Council for Responsible Nutrition and Global Organization for EPA and DHA Omega-3s. Service: 03/22/2018 by email. [507389] [18-1247] [Deanna Okun] [Entered: 03/22/2018 07:40 PM] (2) |
| Mar 22, 2018 | 68 | Entry of appearance for Paul M. Bartkowski as of counsel for Council for Responsible Nutrition and Global Organization for EPA and DHA Omega-3s. Service: 03/22/2018 by email. [507390] [18-1247] [Deanna Okun] [Entered: 03/22/2018 07:48 PM] (2) |
| Mar 22, 2018 | 69 | Entry of appearance for Asha Allam as of counsel for Council for Responsible Nutrition and Global Organization for EPA and DHA Omega-3s. Service: 03/22/2018 by email. [507391] [18-1247] [Deanna Okun] [Entered: 03/22/2018 07:50 PM] (2) |
| Mar 22, 2018 | 70 | Entry of appearance for Paulina M. Starostka as of counsel for Council for Responsible Nutrition and Global Organization for EPA and DHA Omega-3s. Service: 03/22/2018 by email. [507392] [18-1247] [Deanna Okun] [Entered: 03/22/2018 07:51 PM] (2) |
| Mar 21, 2018 | 63 | Notice to counsel for Intervenors Nordic Naturals, Inc. and Nordic Pharma, Inc.: The record of this case indicates that a Certificate of Interest and Docketing Statement have not been filed. Please file the documents promptly. Service as of this date by the Clerk of Court. [506892] [CMP] [Entered: 03/21/2018 11:24 AM] (0) |
| Mar 19, 2018 | 60 | TENDERED from Appellee ITC. Title: RESPONSE BRIEF. Service: 03/19/2018 by email. [506311] [18-1247] [Houda Morad] [Entered: 03/19/2018 04:09 PM] (100) |
| Mar 19, 2018 | 61 | TENDERED from Intervenors Royal DSM NV, DSM Marine Lipids Peru S.A.C., DSM Nutritional Products LLC, DSM Nutritional Products Canada, Inc., Pharmavite LLC, Nordic Naturals, Inc. and Nordic Pharma, Inc.. Title: INTERVENOR BRIEF. Service: 03/19/2018 by email. [506366] [18-1247] [Mark Davies] [Entered: 03/19/2018 06:48 PM] (95) |
| Mar 19, 2018 | 62 | BRIEF FILED for Appellee ITC [60]. Number of Pages: 63. Service: 03/19/2018 by email. The paper copies of the brief should be received by the court on or before 03/28/2018. Appellants Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Ltd. reply brief is due 04/02/2018. [506886] [CMP] [Entered: 03/21/2018 11:06 AM] (100) |
| Mar 19, 2018 | 74 | BRIEF FILED for Intervenors DSM Marine Lipids Peru S.A.C., DSM Nutritional Products Canada, Inc., DSM Nutritional Products LLC, Nordic Naturals, Inc., Nordic Pharma, Inc., Pharmavite LLC and Royal DSM NV [61]. Number of Pages: 73. Service: 03/19/2018 by email. The paper copies of the brief should be received by the court on or before 04/03/2018. Appellants Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Ltd. reply brief is due 04/02/2018. [508324] [CMP] [Entered: 03/27/2018 02:55 PM] (95) |
| Feb 27, 2018 | 58 | Letter from United States of America regarding motion by appellee and intervenors for an extension. Service: 02/27/2018 by email. [501407] [Joseph Busa] [Entered: 02/27/2018 01:48 PM] (1) |
| Feb 27, 2018 | 59 | ORDER filed. The motion [55] is granted. The appellee and intervenors' briefs are due March 19, 2018. Service: 02/27/2018 by clerk. [501505] [LMS] [Entered: 02/27/2018 03:58 PM] (2) |
| Feb 26, 2018 | 56 | RESPONSE of Appellants Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Ltd. to the motion to extend time to file appellee/respondent/cross-appellant principal brief [55] filed by Appellee ITC and Intervenors Nordic Naturals, Inc., Royal DSM NV, DSM Marine Lipids Peru S.A.C., DSM Nutritional Products LLC, DSM Nutritional Products Canada, Inc., Pharmavite LLC and Nordic Pharma, Inc. in 18-1247 , motion to extend time to file intervenor's brief [55] filed by Appellee ITC and Intervenors Nordic Naturals, Inc., Royal DSM NV, DSM Marine Lipids Peru S.A.C., DSM Nutritional Products LLC, DSM Nutritional Products Canada, Inc., Pharmavite LLC and Nordic Pharma, Inc. in 18-1247. Service: 02/26/2018 by email. [500968] [Ashley Parrish] [Entered: 02/26/2018 11:13 AM] (11) |
| Feb 26, 2018 | 57 | REPLY of Appellee ITC and Intervenors DSM Marine Lipids Peru S.A.C., DSM Nutritional Products Canada, Inc., DSM Nutritional Products LLC, Nordic Naturals, Inc., Nordic Pharma, Inc., Pharmavite LLC and Royal DSM NV to response filed by Appellants in 18-1247 , Doc. No [56]. Service: 02/26/2018 by email. [501202] [Mark Davies] [Entered: 02/26/2018 06:18 PM] (15) |
| Feb 23, 2018 | 55 | MOTION of Appellee ITC and Intervenors DSM Marine Lipids Peru S.A.C., DSM Nutritional Products Canada, Inc., DSM Nutritional Products LLC, Nordic Naturals, Inc., Nordic Pharma, Inc., Pharmavite LLC and Royal DSM NV to extend the time to 03/19/2018 to file the appellee/respondent/cross-appellant's principal brief. Any response is due within 10 days of service, to extend the time to 03/19/2018 to file the intervenor's brief. Any response is due within 10 days of service [Consent: not addressed]. Service: 02/23/2018 by email. [500726] [Mark Davies] [Entered: 02/23/2018 01:50 PM] (16) |
| Feb 1, 2018 | 54 | 6 paper copies of the Corrected Consolidated Opening Brief [53] received from Appellants Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Ltd. [494321] [CFT] [Entered: 02/01/2018 10:35 AM] (0) |
| Jan 24, 2018 | 51 | Notice of Correction to the Brief Doc No. [50] for Appellants Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Ltd.. Service: 01/24/2018 by email. [492387] [Ashley Parrish] [Entered: 01/24/2018 02:49 PM] (3) |
| Jan 24, 2018 | 52 | TENDERED from Appellants Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Ltd.. Title: CORRECTED OPENING BRIEF. Service: 01/24/2018 by email. [492391] [Ashley Parrish] [Entered: 01/24/2018 02:53 PM] (86) |
| Jan 24, 2018 | 53 | CORRECTED BRIEF FILED for Appellants Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Ltd. [52]. Number of Pages: 68. Service: 01/24/2018 by email. The paper copies of the brief should be received by the court on or before 02/01/2018. Appellee International Trade Commission brief is due 03/05/2018. Intervenor brief is due 03/05/2018. [492677] [CMP] [Entered: 01/25/2018 11:38 AM] (86) |
| Jan 22, 2018 | 49 | ORDER filed. Nordic's motion to intervene [25] is granted. The revised official caption is reflected in the order. DSM's motion to dismiss [35] is denied. The parties are directed to address the jurisdictional issue in their respective merits briefs. Amarin's opening brief continues to be due no later than ten days after filing of the certified list, and the parties should not anticipate extensions of time. All other pending motions [36] [37] [39] [38] are denied as moot. Service: 01/22/2018 by clerk. [491370] [LMS] [Entered: 01/22/2018 12:10 PM] (3) |
| Jan 22, 2018 | 50 | TENDERED from Appellants Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Ltd.. Title: OPENING BRIEF. Service: 01/22/2018 by email. [491656] This brief has been corrected. See Doc No. [53]. [Ashley Parrish] [Entered: 01/22/2018 07:45 PM] (0) |
| Jan 12, 2018 | 45 | REPLY of Intervenors DSM Marine Lipids Peru S.A.C., DSM Nutritional Products Canada, Inc., DSM Nutritional Products LLC, Pharmavite LLC and Royal DSM NV to response filed by Appellee in 18-1247 , Doc. No [41], response filed by Appellants in 18-1247 , Doc. No [40]. Service: 01/12/2018 by email. [489305] [Mark Davies] [Entered: 01/12/2018 01:03 PM] (10) |
| Jan 12, 2018 | 46 | REPLY of Appellants Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Ltd. to response filed by Intervenors in 18-1247 , Doc. No [44]. Service: 01/12/2018 by email. [489314] [Ashley Parrish] [Entered: 01/12/2018 01:33 PM] (11) |
| Jan 12, 2018 | 47 | Entry of appearance for Robert S. Shwarts as of counsel for Intervenors DSM Marine Lipids Peru S.A.C., DSM Nutritional Products Canada, Inc., DSM Nutritional Products LLC, Pharmavite LLC and Royal DSM NV. Service: 01/12/2018 by email. [489434] [Robert Shwarts] [Entered: 01/12/2018 03:58 PM] (2) |
| Jan 12, 2018 | 48 | Entry of appearance for Jordan L. Coyle as of counsel for Intervenors DSM Marine Lipids Peru S.A.C., DSM Nutritional Products Canada, Inc., DSM Nutritional Products LLC, Pharmavite LLC and Royal DSM NV. Service: 01/12/2018 by email. [489437] [Jordan Coyle] [Entered: 01/12/2018 04:00 PM] (2) |
| Jan 11, 2018 | 43 | RESPONSE of Intervenors DSM Marine Lipids Peru S.A.C., DSM Nutritional Products Canada, Inc., DSM Nutritional Products LLC, Pharmavite LLC and Royal DSM NV to the motion to clarify [37] filed by Appellee ITC in 18-1247 , motion to set briefing schedule [37] filed by Appellee ITC in 18-1247 , motion to extend time to file a response/reply [37] filed by Appellee ITC in 18-1247. Service: 01/11/2018 by email. [488846] [Mark Davies] [Entered: 01/11/2018 08:42 AM] (16) |
| Jan 11, 2018 | 44 | RESPONSE of Intervenors DSM Marine Lipids Peru S.A.C., DSM Nutritional Products Canada, Inc., DSM Nutritional Products LLC, Pharmavite LLC and Royal DSM NV to the motion for other relief [38] filed by Appellants Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Ltd. in 18-1247. Service: 01/11/2018 by email. [488996] [Mark Davies] [Entered: 01/11/2018 01:27 PM] (14) |
| Jan 10, 2018 | 41 | RESPONSE of Appellee ITC to the motion to clarify [36] filed by Intervenors Royal DSM NV, DSM Marine Lipids Peru S.A.C., DSM Nutritional Products LLC, DSM Nutritional Products Canada, Inc. and Pharmavite LLC in 18-1247. Service: 01/10/2018 by email. [488622] [Houda Morad] [Entered: 01/10/2018 11:26 AM] (6) |
| Jan 10, 2018 | 42 | Certified list from the United States International Trade Commission. Service: 01/10/2018 by US mail. [488774] [CMP] [Entered: 01/10/2018 04:08 PM] (7) |
| Jan 9, 2018 | 40 | RESPONSE of Appellants Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Ltd. to the motion to clarify [36] filed by Intervenors Royal DSM NV, DSM Marine Lipids Peru S.A.C., DSM Nutritional Products LLC, DSM Nutritional Products Canada, Inc. and Pharmavite LLC in 18-1247. Service: 01/09/2018 by email. [488455] [Ashley Parrish] [Entered: 01/09/2018 04:35 PM] (9) |
| Jan 8, 2018 | 36 | MOTION of Intervenors DSM Marine Lipids Peru S.A.C., DSM Nutritional Products Canada, Inc., DSM Nutritional Products LLC, Pharmavite LLC and Royal DSM NV to clarify [23]. Any response is due within 10 days of service [Consent: opposed]. Service: 01/08/2018 by email. [487891] [Mark Davies] [Entered: 01/08/2018 11:46 AM] (9) |
| Jan 8, 2018 | 37 | MOTION of Appellee ITC to clarify [23]. Any response is due within 10 days of service, to set briefing schedule. Any response is due within 10 days of service, to extend the time to 02/16/2018 at 05:00 pm file a response/reply to the motion to terminate appeal [35]. [Consent: partial consent]. Service: 01/08/2018 by email. [488095] [Houda Morad] [Entered: 01/08/2018 05:07 PM] (17) |
| Jan 8, 2018 | 38 | MOTION of Appellants Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Ltd. to Refer Motion to Dismiss to the Merits Panel and to Require Jurisdictional Issues to be Addressed in Briefing on the Merits. Any response is due within 10 days of service [Consent: opposed]. Service: 01/08/2018 by email. [488106] [Ashley Parrish] [Entered: 01/08/2018 07:05 PM] (20) |
| Jan 8, 2018 | 39 | MOTION of Appellants Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Ltd. to set briefing schedule. Any response is due within 10 days of service [Consent: unopposed]. Service: 01/08/2018 by email. [488107] [Ashley Parrish] [Entered: 01/08/2018 07:08 PM] (10) |
| Jan 5, 2018 | 34 | Amended Certificate of Interest for the Intervenors DSM Marine Lipids Peru S.A.C., DSM Nutritional Products Canada, Inc., DSM Nutritional Products LLC, Pharmavite LLC and Royal DSM NV. Service: 01/05/2018 by email. [487589] [Mark Davies] [Entered: 01/05/2018 12:23 PM] (4) |
| Jan 5, 2018 | 35 | MOTION of Intervenors DSM Marine Lipids Peru S.A.C., DSM Nutritional Products Canada, Inc., DSM Nutritional Products LLC, Pharmavite LLC and Royal DSM NV to terminate appeal through Dismissal for Lack of Jurisdiction. [Consent: opposed]. Service: 01/05/2018 by email. [487592] [Mark Davies] [Entered: 01/05/2018 12:29 PM] (36) |
| Jan 4, 2018 | 27 | Entry of appearance for Lisa M. Dwyer as of counsel for Appellants Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Ltd.. Service: 01/04/2018 by email. [487305] [Lisa Dwyer] [Entered: 01/04/2018 11:12 AM] (2) |
| Jan 4, 2018 | 28 | RESPONSE of Appellants Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Ltd. to the motion for leave to intervene [25]. Service: 01/04/2018 by email. [487307] [Ashley Parrish] [Entered: 01/04/2018 11:16 AM] (8) |
| Jan 4, 2018 | 29 | Entry of appearance for Andrew D. Silverman as of counsel for Intervenors DSM Marine Lipids Peru S.A.C., DSM Nutritional Products Canada, Inc., DSM Nutritional Products LLC, Pharmavite LLC and Royal DSM NV. Service: 01/04/2018 by email. [487473] [Andrew Silverman] [Entered: 01/04/2018 07:18 PM] (2) |
| Jan 4, 2018 | 30 | Entry of appearance for Annette L. Hurst as of counsel for Intervenors DSM Marine Lipids Peru S.A.C., DSM Nutritional Products Canada, Inc., DSM Nutritional Products LLC, Pharmavite LLC and Royal DSM NV. Service: 01/04/2018 by email. [487477] [Annette Hurst] [Entered: 01/04/2018 07:23 PM] (2) |
| Jan 4, 2018 | 31 | Entry of appearance for Alec Schierenbeck as of counsel for Intervenors DSM Marine Lipids Peru S.A.C., DSM Nutritional Products Canada, Inc., DSM Nutritional Products LLC, Pharmavite LLC and Royal DSM NV. Service: 01/04/2018 by email. [487478] [Alec Schierenbeck] [Entered: 01/04/2018 07:26 PM] (2) |
| Jan 4, 2018 | 32 | Certificate of Interest for the Intervenors DSM Marine Lipids Peru S.A.C., DSM Nutritional Products Canada, Inc., DSM Nutritional Products LLC, Pharmavite LLC and Royal DSM NV. Service: 01/04/2018 by email. [487479] [Mark Davies] [Entered: 01/04/2018 07:29 PM] (4) |
| Jan 4, 2018 | 33 | Docketing Statement for the Intervenors DSM Marine Lipids Peru S.A.C., DSM Nutritional Products Canada, Inc., DSM Nutritional Products LLC, Pharmavite LLC and Royal DSM NV. Service: 01/04/2018 by email. [487480] [Mark Davies] [Entered: 01/04/2018 07:31 PM] (3) |
| Jan 3, 2018 | 26 | RESPONSE of Appellee ITC to the motion for leave to intervene [25]. Service: 01/03/2018 by email. [487113] [Houda Morad] [Entered: 01/03/2018 02:49 PM] (5) |
| Jan 2, 2018 | 23 | ORDER filed. The motion to intervene [14] is granted. The revised official caption is reflected in the order. The motion to modify the briefing schedule [15] is denied. (Per Curiam). Service: 01/02/2018 by clerk. [486604] [LMS] [Entered: 01/02/2018 12:31 PM] (3) |
| Jan 2, 2018 | 24 | Entry of appearance for Andrew F. Pratt as principal counsel for Nordic Naturals, Inc. and Nordic Pharma, Inc.. Service: 01/02/2018 by email. [486831] [Andrew Pratt] [Entered: 01/02/2018 09:00 PM] (2) |
| Jan 2, 2018 | 25 | MOTION of Proposed Intervenors Nordic Naturals, Inc. and Nordic Pharma, Inc. for leave to intervene. Any response is due within 10 days of service [Consent: opposed]. Service: 01/02/2018 by email. [486832] [Andrew Pratt] [Entered: 01/02/2018 09:03 PM] (13) |
| Dec 28, 2017 | 22 | Docketing Statement for the Appellee ITC. Service: 12/28/2017 by email. [486096] [Houda Morad] [Entered: 12/28/2017 02:52 PM] (4) |
| Dec 15, 2017 | 20 | REPLY of Proposed-Intervenors Royal DSM NV, DSM Marine Lipids Peru S.A.C., DSM Nutritional Products LLC, DSM Nutritional Products Canada, Inc., and Pharmavite LLC to response filed by Appellants in 18-1247 , Doc. No [16], response filed by Appellee in 18-1247 , Doc. No [19]. Service: 12/15/2017 by email. [482924] [Mark Davies] [Entered: 12/15/2017 11:44 AM] (17) |
| Dec 15, 2017 | 21 | REPLY of Proposed-Intervenors Royal DSM NV, DSM Marine Lipids Peru S.A.C., DSM Nutritional Products LLC, DSM Nutritional Products Canada, Inc., and Pharmavite LLC to response filed by Appellants in 18-1247 , Doc. No [17], response filed by Appellee in 18-1247 , Doc. No [18]. Service: 12/15/2017 by email. [482926] [Mark Davies] [Entered: 12/15/2017 11:46 AM] (14) |
| Dec 14, 2017 | 18 | RESPONSE of Appellee ITC to the motion to set briefing schedule [15]. Service: 12/14/2017 by email. [482582] [Houda Morad] [Entered: 12/14/2017 10:18 AM] (8) |
| Dec 14, 2017 | 19 | RESPONSE of Appellee ITC to the motion for leave to intervene [14]. Service: 12/14/2017 by email. [482586] [Houda Morad] [Entered: 12/14/2017 10:22 AM] (12) |
| Dec 13, 2017 | 16 | RESPONSE of Appellants Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Ltd. to the motion for leave to intervene [14]. Service: 12/13/2017 by email. [482453] [Ashley Parrish] [Entered: 12/13/2017 03:16 PM] (9) |
| Dec 13, 2017 | 17 | RESPONSE of Appellants Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Ltd. to the motion to set briefing schedule [15]. Service: 12/13/2017 by email. [482455] [Ashley Parrish] [Entered: 12/13/2017 03:18 PM] (12) |
| Dec 11, 2017 | 13 | Entry of appearance for Mark S. Davies as principal counsel for Royal DSM NV, DSM Marine Lipids Peru S.A.C., DSM Nutritional Products, LLC, DSM Nutritional Products Canada, Inc., and Pharmavite LLC. Service: 12/11/2017 by email. [481668] [Mark Davies] [Entered: 12/11/2017 03:27 PM] (2) |
| Dec 11, 2017 | 14 | MOTION of Proposed-Intervenors Royal DSM NV, DSM Marine Lipids Peru S.A.C., DSM Nutritional Products LLC, DSM Nutritional Products Canada, Inc., and Pharmavite LLC for leave to intervene. Any response is due within 10 days of service [Consent: opposed]. Service: 12/11/2017 by email. [481675] [Mark Davies] [Entered: 12/11/2017 03:36 PM] (13) |
| Dec 11, 2017 | 15 | MOTION of Proposed-Intervenors Royal DSM NV, DSM Marine Lipids Peru S.A.C., DSM Nutritional Products LLC, DSM Nutritional Products Canada, Inc., and Pharmavite LLC to set briefing schedule. Any response is due within 10 days of service [Consent: opposed]. Service: 12/11/2017 by email. [481678] [Mark Davies] [Entered: 12/11/2017 03:42 PM] (12) |
| Dec 5, 2017 | 11 | ORDER filed. Amarin's motions [8] [479748-2] [7] are granted to the following extent: Appeal Nos. 2018-1247 and -114 are consolidated. The revised official caption is reflected in the order. Amarin's consolidated opening brief must make all of its requests for relief, including mandamus relief. The petition filed as Docket Entry No. 2 [479703-2] in 2018-114 shall not be transmitted to the merits panel. Any response by the Commission to Amarin's request for mandamus relief must be included within the context of its consolidated response brief. The Commission should not anticipate any extensions of time for the filing of its brief. This case will be placed on the earliest available oral argument calendar after briefing is completed. The certified list is due January 10, 2018, and Amarin's consolidated opening brief is due no later than ten days thereafter. (Per Curiam). Service: 12/05/2017 by clerk. [480352] [18-1247, 18-114] [LMS] [Entered: 12/05/2017 02:35 PM] (3) |
| Dec 5, 2017 | 12 | Note to file: The following cases are associated: 18-1247 Lead with 18-114 Consolidated. FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [480417] [18-1247, 18-114] [CMP] [Entered: 12/05/2017 04:34 PM] (0) |
| Dec 4, 2017 | 9 | Entry of appearance for Houda Morad as principal counsel for Appellee ITC. Service: 12/04/2017 by email. [480079] [Houda Morad] [Entered: 12/04/2017 05:05 PM] (2) |
| Dec 4, 2017 | 10 | Entry of appearance for Wayne W. Herrington as of counsel for Appellee ITC. Service: 12/04/2017 by email. [480086] [Wayne Herrington] [Entered: 12/04/2017 05:12 PM] (2) |
| Dec 1, 2017 | 1 | Appeal docketed. Received: 12/01/2017. [479730] Entry of Appearance due 12/15/2017. Certificate of Interest is due on 12/15/2017. Docketing Statement due 01/02/2018. Certified List due on 01/10/2018. [CMP] [Entered: 12/01/2017 04:58 PM] (10) |
| Dec 1, 2017 | 2 | Entry of appearance for Ashley C. Parrish as principal counsel for Appellants Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Ltd.. Service: 12/01/2017 by hand delivery. [479731] [CMP] [Entered: 12/01/2017 05:01 PM] (2) |
| Dec 1, 2017 | 3 | Entry of appearance for Jeffery M. Telep as of counsel for Appellants Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Ltd.. Service: 12/01/2017 by hand delivery. [479732] [CMP] [Entered: 12/01/2017 05:02 PM] (2) |
| Dec 1, 2017 | 4 | Entry of appearance for Jesse Snyder as of counsel for Appellants Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Ltd.. Service: 12/01/2017 by hand delivery. [479733] [CMP] [Entered: 12/01/2017 05:04 PM] (2) |
| Dec 1, 2017 | 5 | Certificate of Interest for the Appellants Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Ltd.. Service: 12/01/2017 by email. [479737] [Ashley Parrish] [Entered: 12/01/2017 05:22 PM] (4) |
| Dec 1, 2017 | 6 | Docketing Statement for the Appellants Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Ltd.. Service: 12/01/2017 by email. [479738] [Ashley Parrish] [Entered: 12/01/2017 05:27 PM] (3) |
| Dec 1, 2017 | 7 | MOTION of Appellants Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Ltd. to expedite case. Any response is due within 10 days of service [Consent: opposed]. Service: 12/01/2017 by email. [479742] [Ashley Parrish] [Entered: 12/01/2017 05:42 PM] (190) |
| Dec 1, 2017 | 8 | MOTION of Appellants Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Ltd. to consolidate appeals (18-1247 and 18-114). Any response is due within 10 days of service [Consent: opposed]. Service: 12/01/2017 by email. [479744] [Ashley Parrish] [Entered: 12/01/2017 05:48 PM] (11) |
